Skip to main content

AIA Group Ltd

Position in NBIX — Neurocrine Biosciences Inc

CIK 1522877 HONG KONG, K3

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$210,000
+$5,907 QoQ
Shares Held
1,246
-13.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#599
of 773 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

AIA Group Ltd holds $3,932,593 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (5.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
1,246 $210,000

All Filings in NBIX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $210,000 1,246
2025-12-31 $204,093 1,439
2025-09-30 $217,167 1,547
2025-06-30 $223,853 1,781
2025-03-31 $213,568 1,931
2024-12-31 $232,186 1,701
2023-03-31 $213,068 2,105
2022-12-31 $289,522 2,424
2022-06-30 $159,867 1,640